SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-053908
Filing Date
2020-11-13
Accepted
2020-11-13 17:00:39
Documents
58
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q pmvp-10q_20200930.htm 10-Q 2608754
2 EX-31.1 pmvp-ex311_6.htm EX-31.1 18386
3 EX-31.2 pmvp-ex312_7.htm EX-31.2 18896
4 EX-32.1 pmvp-ex321_8.htm EX-32.1 9630
5 EX-32.2 pmvp-ex322_9.htm EX-32.2 9858
  Complete submission text file 0001564590-20-053908.txt   6423378

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT pmvp-20200930.xml EX-101.INS 1086128
7 XBRL TAXONOMY EXTENSION SCHEMA pmvp-20200930.xsd EX-101.SCH 36608
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pmvp-20200930_cal.xml EX-101.CAL 33085
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pmvp-20200930_def.xml EX-101.DEF 105662
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE pmvp-20200930_lab.xml EX-101.LAB 317491
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pmvp-20200930_pre.xml EX-101.PRE 246614
Mailing Address 8 CLARKE DRIVE CRANBURY NJ 08512
Business Address 8 CLARKE DRIVE CRANBURY NJ 08512 (609) 642-6664
PMV Pharmaceuticals, Inc. (Filer) CIK: 0001699382 (see all company filings)

IRS No.: 463218129 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39539 | Film No.: 201312356
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences